ISPOR - FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

Full Text

FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

Abstract

Authors

R. Macaulay

Back to Volume 18, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now